Andrea L Bauchat

Medical Instructor in the Department of Pediatrics

Pediatrics, Transplant and Cellular Therapy

andrea.bauchat@duke.edu

AT A GLANCE

Credentials

Academic Experience
1. Current Appointments & Affiliations

Expertise

Research
1. Selected Grants

Publications
1. Selected Publications

Artistic Works / Events

Teaching
1. Recent Courses

Advising & Mentoring

Recognition

Professional Activities

Manage Profile

Embed Profile Data

Selected Publications

Allogeneic hematopoietic cell transplantation is effective for p47phox chronic granulomatous disease: A Primary Immune Deficiency Treatment Consortium study.

Journal Article J Allergy Clin Immunol · May 2024 BACKGROUND: P47phox (neutrophil cytosolic factor-1) deficiency is the most common cause of autosomal recessive chronic granulomatous disease (CGD) and is considered to be associated with a milder clinical phenotype. Allogeneic hematopoietic cell transplant ... Full text Link to item Cite

Genotype, oxidase status, and preceding infection or autoinflammation do not affect allogeneic HCT outcomes for CGD.

Journal Article Blood · December 14, 2023 Chronic granulomatous disease (CGD) is a primary immunodeficiency characterized by life-threatening infections and inflammatory conditions. Hematopoietic cell transplantation (HCT) is the definitive treatment for CGD, but questions remain regarding patient ... Full text Link to item Cite

ANTI-CD38 MOAB DARATUMUMAB IS EFFECTIVE IN THE TREATMENT OF POST-TRANSPLANT PURE RED CELL APLASIA AND REFRACTORY AUTOIMMUNE HEMOLYTIC ANEMIA IN AN INFANT WITH HURLER SYNDROME

Conference PEDIATRIC BLOOD & CANCER · 2023 Cite

NEWBORN SCREENING FOR HURLER SYNDROME LEADS TO EARLY TREATMENT AND EXCELLENT OUTCOMES WITH UNRELATED UMBILICAL CORD BLOOD TRANSPLANT

Conference BONE MARROW TRANSPLANTATION · 2023 Cite

OUTCOMES OF UMBILICAL CORD BLOOD TRANSPLANTATION IN CHILDREN WITH CHRONIC GRANULOMATOUS DISEASE

Conference BONE MARROW TRANSPLANTATION · 2023 Cite